Per-Anders Broliden - Concepedia

Author

Per-Anders Broliden

Also Known As

PER-ANDERS BROLIDEN, Per-Anders Broliden, PerAnders Broliden

Publications

713

Citations

H-Index

Concepts

All Affiliations

Per-Anders Broliden is an author at Karolinska Institutet specializing in hiv, immunology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	53
2	Immunology	2	2	53
3	Biomolecular Engineering	1	1	43
4	Cell Biology	1	1	43
5	Immunotherapy	1	1	43

Per-Anders Broliden

Publications

698

Citations

H-Index

Page 1

	Year	Citations
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL) Jeanette Lundin, Eva Kimby, Magnus Björkholm, Blood	2002	496
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp 120 Lennart Åkerblom, Jorma Hinkula, Per-Anders Broliden, AIDS	1990	89
Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency Jan Albert, Anders Nauclér, Blenda Böttiger, AIDS	1990	49
A Human Monoclonal Antibody to HIV-1 gp41 with Neutralizing Activity Against Diverse Laboratory Isolates Joseph Cotropia, Kenneth E. Ugen, Srisakul Kliks, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology NeurovirologyHuman Monoclonal AntibodyMedicineImmunologyEpitope Mapping	1996	43
Monoclonal Antibodies to Conserved Regions of the Major Core Protein ( <i>gag</i> 24) of HIV-1 and HIV-2 Emilio Carpio, Carlos A. Duarte, Jorma Hinkula, AIDS Research and Human Retroviruses	1991	11
Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160 Kristina Broliden, Jorma Hinkula, Göran Bratt, Clinical and Diagnostic Virology VaccinationHiv-1-infected IndividualsVaccine TargetHuman RetrovirusHumoral Response	1996	10

Page 1